Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 785
- 试验地点
- 1
- 主要终点
- Number of Participants Who Had Significant Hypotension as Defined in the Protocol as Need for Norepinephrine Dose >0.1mcq/kg/Min in the First 72 Hours Postoperatively
研究概览
简要总结
Cardiopulmonary bypass is done with a machine that does the work of the heart and lungs during open-heart surgery. This study is to determine if intravenous (i.v.) phenoxybenzamine is safe. This drug lowers the blood pressure, making it easier for the cardiopulmonary bypass machine to deliver blood and oxygen to all of the organs and tissues.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- — 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •0-18 years of age
- •weight of less than or equal to 20 kilograms
排除标准
- •Parental refusal to give informed consent
研究组 & 干预措施
1
Receive phenoxybenzamine in preparation for cardiopulmonary bypass during open-heart surgery
干预措施: Phenoxybenzamine (Drug)
结局指标
主要结局
Number of Participants Who Had Significant Hypotension as Defined in the Protocol as Need for Norepinephrine Dose >0.1mcq/kg/Min in the First 72 Hours Postoperatively
时间窗: 72 hours postoperatively
Number of subjects who required Norepinephrine \>0.1mcq/kg/min
次要结局
未报告次要终点
